Company intelligence / Profile preview

Ashbourne Pharmaceuticals

Arthingworth, Leicestershire, United Kingdom

Ownership: Private
Employees: ~89
Development stage: Other

Overview

Ashbourne Pharmaceuticals (operating as DB Ashbourne) is a UK-based specialty pharmaceutical company that focuses on the supply and marketing of branded generic and off-patent medicines. Acquired by the French group Ethypharm in 2015, the company serves as the primary commercial arm for Ethypharm's operations in the United Kingdom. Its portfolio is centered on pain management, addiction treatments, and dermatology, with the goal of providing high-quality, cost-effective therapeutic options to the National Health Service (NHS).

Therapeutic areas: PsychiatryEndocrinologyNeurologyDermatology
Modalities: Small molecule
Industry: Biotech

Partnerships

National Health Service

Beyond the preview

Go deeper on Ashbourne Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ashbourne Pharmaceuticals.

Explore the full profile